Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
Yadav DK, Saloni, Sharma P, Misra S, Singh H, Mancera RL, Kim K, Jang C, Kim MH, Pérez-Sánchez H, Choi EH, Kumar S.
Yadav DK, et al. Among authors: kumar s.
Arch Pharm Res. 2018 Dec;41(12):1178-1189. doi: 10.1007/s12272-017-0945-7. Epub 2017 Aug 18.
Arch Pharm Res. 2018.
PMID: 28822076